Earnings Call · Q4 FY2022·2023-02-07

Q4 22EPS +7.12%·Rev n/aQ3 22EPS +10.16%·Rev n/aQ2 22EPS +2.86%·Rev n/aQ1 22EPS -0.56%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Susie Lisa — Senior Vice President, Investor Relations

Reshma Kewalramani — Chief Executive Officer

Stuart Arbuckle — Chief Operating Officer

Charlie Wagner — Chief Financial Officer

−4.9%1d on move date−3.8% vs SPY3d−3.6%5d−2.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access